Cancer Gene Therapy - Table of Contents alert Volume 24 Issue 7

If you are unable to see the message below, click here to view.

Advertisement Cell and gene therapies offer tremendous hope, yet immense complexities. Innovators must overcome unprecedented challenges to bring these products to patients...but where do they start? In our newest white paper, AmerisourceBergen offers more than 70 pages of insights on what it takes to design and execute an effective commercialization strategy when the patient is in the supply chain. Read more TABLE OF CONTENTS Volume 24, Issue 7 (July 2017) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Original Articles Top Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients OPEN K Fujita, Y Nakai, A Kawashima, T Ujike, A Nagahara, T Nakajima, T Inoue, C M Lee, M Uemura, Y Miyagawa, Y Kaneda and N Nonomura Cancer Gene Ther 2017 24: 277-281; advance online publication, May 12, 2017; 10.1038/cgt.2017.15 Abstract | Full Text Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma Z Deng, Y Wang, X Fang, F Yan, H Pan, L Gu, C Xie, Y Li, Y Hu, Y Cao and Z Tang Cancer Gene Ther 2017 24: 282-288; advance online publication, June 16, 2017; 10.1038/cgt.2017.18 Abstract | Full Text Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro H Saito, K Kitagawa, T Yoneda, Y Fukui, M Fujsawa, D Bautista and T Shirakawa Cancer Gene Ther 2017 24: 289-296; advance online publication, June 16, 2017; 10.1038/cgt.2017.21 Abstract | Full Text An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions C Xu, X Yang, Y Wang, N Ding, R Han, Y Sun and Y Wang Cancer Gene Ther 2017 24: 297-303; advance online publication, May 19, 2017; 10.1038/cgt.2017.17 Abstract | Full Text The novel gene HA117 promotes in vitro and in vivo drug resistance in mouse colon tumor cells Y X Guo, Y H Xu, G H Zheng and X Q Jin Cancer Gene Ther 2017 24: 304-308; advance online publication, July 21, 2017; 10.1038/cgt.2017.28 Abstract | Full Text PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer R-K Li, J- Gao, L-H Guo, G-Q Huang and W-H Luo Cancer Gene Ther 2017 24: 309-315; advance online publication, July 21, 2017; 10.1038/cgt.2017.29 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.